KYTHERA BIOPHARMACEUTICALS INC (KYTH) has 15 open-market insider trades by 6 insiders since 2015. The most active filer is John W. Smither, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Frederick Beddingfield III | Chief Medical Officer | — | 3 | $10.7M | 2015-10-01 |
| Elisabeth Sandoval | Chief Commerical Officer | — | 3 | $6.5M | 2015-10-01 |
| John W. Smither | CFO | — | 4 | $5.0M | 2015-10-01 |
| Keith Klein | General Counsel | — | 3 | $4.8M | 2015-10-01 |
| Keith R. Leonard | Pres | — | 1 | $252K | 2015-10-01 |
| Douglas A. Rich | PresVP | — | 1 | $45K | 2015-10-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Frederick Beddingfield III | Chief Medical Officer | Sell | $8.3M | 2015-09-24 |
| Keith Klein | General Counsel | Sell | $3.9M | 2015-09-23 |
| John W. Smither | CFO | Sell | $4.0M | 2015-09-23 |
| Elisabeth Sandoval | Chief Commercial Officer | Sell | $6.2M | 2015-09-22 |
| Keith Klein | General Counsel | Sell | $793K | 2015-09-22 |
| John W. Smither | CFO | Sell | $498K |
Companies that share insiders with KYTH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2015-09-18 |
| Camille D. Samuels | Director | Sell | $19K | 2015-09-01 |
| Elisabeth Sandoval | Chief Commercial Officer | Sell | $204K | 2015-08-05 |
| Camille D. Samuels | Director | Sell | $19K | 2015-08-03 |
| Camille D. Samuels | Director | Sell | $19K | 2015-07-01 |
| John W. Smither | CFO | Sell | $347K | 2015-06-25 |
| Frederick Beddingfield III | Chief Medical Officer | Sell | $2.3M | 2015-06-24 |
| Keith R. Leonard | President | Sell | $844K | 2015-06-01 |
| Camille D. Samuels | Director | Sell | $12K | 2015-06-01 |
| Keith R. Leonard | President | Sell | $175K | 2015-05-20 |